COPART vs GMED
COPART (COPART) versus Globus Medical (GMED) — a side-by-side from cached financials, not a winner call.
COPART (COPART) common stock.
Globus Medical (GMED) is a medical devices company listed on US.
COPART does not have a complete income-statement cache yet.
Latest reported GMED revenue for 2026-06-30 was $1.55B. Net income was $275.9M. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
GMED currently screens at market cap $7.66B and trailing P/E 42.1.
Not investment advice. Open the COPART and GMED stock pages for the full models.
Not investment advice.